An Open Label Trial of TMC114/Rtv in HIV-1 Infected Subjects Who Were Randomized in the Trials TMC114-C201, TMC114-C207 or in Sponsor Selected Phase I Trials.
Phase of Trial: Phase II
Latest Information Update: 06 Aug 2014
At a glance
- Drugs Darunavir (Primary) ; Ritonavir
- Indications HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- Sponsors Janssen R&D Ireland
- 10 Jun 2017 Biomarkers information updated
- 06 Jul 2013 Status changed from active, no longer recruiting to completed as reported by European Clinical Trials Database.
- 31 Oct 2011 Status changed from completed to active, no longer recruiting (the EU Clinical Trials Register indicates that the trial is ongoing in the UK but has been completed in other countries).